2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies

2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies


2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies -- Call for Poster Abstracts!

The European Congress on Hematology™: Focus on Lymphoid Malignancies Program Chairs invite you to submit your abstracts for the 2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies to be held 20 and 21 October 2017, at The Westin Paris-Vendôme in Paris, France.

Deadline for submission is 8 September 2017, at 11:59 AM US EDT (5:59 CEDT).

All poster abstracts must be submitted electronically through the congress' online abstract submission system.

Your abstract should be a short description of your work focused on Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma, containing all the elements necessary to define your goals and results to the reader. Authors will be required to disclose all financial relationships through the online system, helping to ensure quality and unbiased presentations. The formal poster session is not designated for credit.

Share your research or best practices with your peers. Categories of submission include:

  • Surgical Oncology
  • Radiation Oncology
  • Pathology
  • Medical Oncology
  • Imaging/ Radiology
  • Basic Biology
  • Epidemiology Risk Assessment/ Prevention
  • Survivorship
  • Other

Note: Trial in progress and encore abstracts are accepted.

The Program chairs will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Incomplete abstracts will not be reviewed.

Notification of acceptance, or regret, will be delivered via e-mail to the presenter(s) of each poster abstract, by mid-September. Please note that an author is required to be present during the poster session.

If accepted for presentation, abstracts and posters will be available for viewing online on the 2017 congress website during and after the conference. The posters will be displayed for the length of the conference. The presentation at the congress should reflect the submitted abstract title, authorship, and content of the presentation at the congress must match the submitted abstract.

All presenters must register to attend the 2nd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies. Please click here to register.

Submission Process

  • Complete the abstract template provided on the 2017 European Congress on Hematology™: Focus on Lymphoid Malignancies website.
  • Limit is 2500 characters (abstract body, including spaces and table).
  • Upload full abstract or poster where prompted.

Components of the Abstract Body-Limit: 2500 Characters (1 table allowed)

  1. Background/Significance -- What was the problem and why was it important? What knowledge are you building on? What was the intent or goal of the study? What did you want to learn?
  2. Materials and Methods -- What was the trial design? What was the sample? What instruments were used? How were data collected and analyzed?
  3. Results -- What were the findings?
  4. Conclusions -- What do the findings mean?

Abstract Questions

Please submit any questions pertaining to abstract submissions to abstracts@gotoper.com using the subject line "European Congress on Hematology™ Abstract QUESTION."

Author Consent and Waiver of Claims

  • Each abstract author agrees and certifies that he or she:
    • Waives any and all claims against Physicians' Education Resource®, LLC, sponsor of the European Congress on Hematology™: Focus on Lymphoid Malignancies, and any review arising out of or relating to the abstract submission and review process, including but not limited to peer review and the grading of abstracts.

Note: The hotel is expected to sell out and likely to do so before the discounted cut-off date of the 1 October 2017. Reservations may be made online here.







Become a Member

Forgot Password?
Filter By